Project Grant R01AA033300
- The National Institute on Alcohol Abuse and Alcoholism awarded the University of Texas Health Science Center at Houston $1.772 million on September 15, 2025, under the Alcohol Research Programs (CFDA 93.273) to develop and validate a microbial-based platform for assessing alcohol-related organ damage in alcohol use disorders. The recipient will develop a comprehensive web-based knowledge module integrating microbiota, metabolites, and host pathways to map microbial signatures and mechanisms...
- The National Institute on Alcohol Abuse and Alcoholism awarded $4,718,683 to the Regents of the University of California, San Francisco on September 25, 2025, under the Alcohol Research Programs (CFDA 93.273) to establish the Center for Alcohol/HIV Innovations and Biomarker Research (CALIBER), a comprehensive research, training, and dissemination program addressing the intersection of unhealthy alcohol use and HIV transmission and comorbidity. CALIBER will develop and pilot test a motivational...
- The National Institute on Alcohol Abuse and Alcoholism awarded Emory University $497,748 under the Alcohol Research Programs (CFDA 93.273) on September 20, 2025, to develop and test an interactive text messaging intervention based on Construal Level Theory to reduce heavy drinking and HIV risk among young adult men. The award supports a K99/R00 career development grant structure in which the applicant will develop and refine theory-based text messaging content during the K99 phase, then test the...
- The National Institute on Alcohol Abuse and Alcoholism awarded the University of Washington $670,594 on September 1, 2026, under the Alcohol Research Programs (CFDA 93.273) to develop and test a personalized text message intervention for young adults addressing anticipated drinking events and protective behavioral strategy use. The intervention delivers a theoretically and clinically informed 3-week text message program tailored to individual anticipated drinking occasions and harm-reduction...
- The National Institute on Alcohol Abuse and Alcoholism awarded the Regents of the University of Michigan $2,105,899 on September 15, 2025, under the Alcohol Research Programs (CFDA 93.273) to conduct a fully-powered randomized controlled trial testing the efficacy of a social-media-based intervention for high-intensity drinking among emerging adults. The intervention delivers eight weeks of motivational interviewing-based content through private social media 1:1 messaging with health coaches,...
- The National Institute on Alcohol Abuse and Alcoholism awarded Yale University $182,183 on September 1, 2026, under the Alcohol Research Programs (CFDA 93.273) to develop artificial intelligence agents that generate personalized, multimedia cognitive behavioral therapy content for alcohol use disorder treatment, targeting English speakers and Spanish speakers. The project will create AI-generated CBT content delivered via smartphone to address high-risk drinking periods, such as weekends. The...
- The National Institute on Alcohol Abuse and Alcoholism awarded the University of Texas at Arlington $720,437 on May 1, 2026, under the Alcohol Research Programs (CFDA 93.273) to conduct a hybrid Type 1 effectiveness-implementation trial evaluating parent-based interventions for adolescent alcohol prevention that incorporate social media content and personalized feedback. The research addresses the gap between evidence that alcohol parent-based interventions reduce adolescent drinking and the...
- The National Institute on Alcohol Abuse and Alcoholism awarded Northwestern University $190,000 under the Alcohol Research Programs (CFDA 93.273) on September 1, 2026, to conduct multilevel research on alcohol use and HIV risk among young men in Chicago. The award funds an exploratory R21 project that will collect data from 150 young men ages 14–29 in Chicago, supplemented by 20 qualitative interviews. Aim 1 will characterize patterns of alcohol-related HIV vulnerability by integrating...
- The National Institute on Alcohol Abuse and Alcoholism awarded The University of Texas Health Science Center at San Antonio $664,792 on September 1, 2026, under the Alcohol Research Programs (CFDA 93.273) to investigate post-transcriptional mechanisms and cellular senescence in age-related alcoholic liver disease. The research targets dysregulated nutrient sensing as a hallmark of aging that drives hepatic steatosis progression toward cirrhosis and hepatocellular carcinoma. The recipient will...
- The National Institute on Alcohol Abuse and Alcoholism awarded Public Health Institute $1,291,065 under the Alcohol Research Programs (CFDA 93.273) on September 20, 2025. The project conducts analyses of alcohol-related mortality in the United States with emphasis on spirits consumption, examining mortality rate relationships with beverage-specific per capita consumption and policy interventions. The work addresses mortality trends that have increased dramatically since 1999 and particularly...
The National Institute on Alcohol Abuse and Alcoholism awarded the University of Houston System $706,832 on August 10, 2026, under the Alcohol Research Programs grant program (CFDA 93.273) to develop and evaluate a personalized digital intervention addressing hazardous alcohol use and negative affect among people with HIV. The intervention, called I-PFI (Integrated Personalized Feedback Intervention), is a single-session, computer-delivered program lasting 20–30 minutes that provides personalized feedback on hazardous alcohol use, negative affect, and HIV-related health outcomes, combined with interactive psychoeducation and evidence-based strategies including interoceptive exposure and related techniques. The intervention targets anxiety sensitivity—the fear of anxiety-related sensations—as a transdiagnostic mechanism driving both hazardous drinking and negative affect symptoms such as anxiety and depression, conditions that occur at elevated rates among people with HIV and contribute to poor antiretroviral therapy adherence, reduced retention in care, and increased mortality. The award funds research at the University of Houston in Houston, Texas, with a period of performance from August 10, 2026, through July 31, 2031. The Alcohol Research Programs portfolio supports development of improved treatment methods and prevention strategies for alcoholism and alcohol-related problems across biomedical, genetic, psychological, and environmental disciplines.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $706.8k | 8/12/26 |